Article Details

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Rating of "Hold" from ...

Retrieved on: 2021-01-02 09:00:00

Tags for this article:

Click the tags to see associated articles and topics

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives Consensus Rating of "Hold" from .... View article details on hiswai:

Excerpt

Zacks Investment Research raised Collegium Pharmaceutical from a "sell" rating to ... Hedge funds have recently bought and sold shares of the stock.

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up